市场调查报告书
商品编码
1354328
柳叶刀市场规模- 按类型(安全柳叶刀、标准柳叶刀、手动启动柳叶刀、自动启动柳叶刀)、按尺寸(22G 及以下、23G-33G、33G 以上)、依最终用途- 全球预测(2023-2032)Lancet Market Size - By Type (Safety Lancets, Standard Lancets, Manually Activated Lancets, Automatically Activated Lancets), By Size (22G and Below, 23G-33G, Above 33G), By End-use - Global Forecast (2023-2032) |
在全球糖尿病盛行率不断上升的推动下,2023 年至 2032 年全球《柳叶刀》市场规模将呈现 4.7% 的复合年增长率。据世界卫生组织称,糖尿病影响全球约 4.22 亿人,其中大多数居住在低收入和中等收入国家。每年,糖尿病直接导致 150 万人死亡。
随着越来越多的人需要定期监测血糖,对获取血液样本至关重要的采血针的需求将会增加。糖尿病管理中对自我保健和早期疾病管理的重视进一步推动了刺血针市场的发展,因为患者寻求方便有效的工具来监测自己的病情,从而创造了市场扩张的机会。
整个刺血针市场根据类型、尺寸、最终用途和地区进行分类。
2023 年至 2032 年间,安全采血针产业的复合年增长率可能为 5.2%。由于对医护人员安全和感染控制的担忧日益增加,对安全采血针的需求正在增长。这些创新设备提供了一种更安全、更卫生的血液采集方式,降低了针刺伤害和交叉污染的风险。因此,医疗机构和专业人员越来越多地采用安全刺血针来增强工作场所安全和病患照护。
诊所可能会成为刺血针的主要最终用户,由于诊断目的对高效、精确的血液采样的需求的推动,到 2032 年,该细分市场的规模将以 4.6% 的复合年增长率扩大。采血针提供了一种快速且相对无痛的方法来获取用于各种医学测试的血液样本。由于诊所为不同的患者群体提供服务,刺血针的可靠性和易用性使其成为医疗保健专业人员的必备工具,满足了他们在临床环境中的高需求。
由于该地区人口老化、糖尿病等慢性病盛行率增加以及对医疗品质和病人安全的高度重视,欧洲刺血针产业正在大幅成长。根据欧盟统计局数据,2022年,欧盟老年扶养比为33%,较前一年上升0.5个百分点,呈现持续上升趋势。自2012年以来的十年间,这项指标从当年的27.1%上升了5.9个百分点。这些因素推动了对血糖监测和诊断至关重要的刺血针的需求,促进了该行业在欧洲的强劲扩张。
Global Lancet Market size will exhibit 4.7% CAGR from 2023 to 2032, driven by the growing prevalence of diabetes worldwide. According to WHO, diabetes affects approximately 422 million individuals globally, with the majority residing in low- and middle-income nations. Each year, diabetes directly contributes to 1.5 million fatalities.
As more individuals require regular blood glucose monitoring, lancets, crucial for obtaining blood samples, will witness increased demand. The emphasis on self-care and early disease management in diabetes management further propels the lancet market, as patients seek convenient and efficient tools for monitoring their condition, creating opportunities for market expansion.
The overall lancet market is categorized based on type, size, end-use, and region.
The safety lancets industry could demonstrate 5.2% CAGR between 2023 and 2032. The demand for safety lancets is gaining momentum due to growing concerns for healthcare worker safety and infection control. These innovative devices offer a safer and more hygienic way to obtain blood samples, reducing the risk of needlestick injuries and cross-contamination. Consequently, healthcare facilities and professionals are increasingly adopting safety lancets to enhance workplace safety and patient care.
Clinics could emerge as a prominent end-user for lancets, with the segment size expanding at 4.6% CAGR through 2032, driven by the need for efficient and precise blood sampling for diagnostic purposes. Lancets provide a quick and relatively painless way to obtain blood samples for various medical tests. With clinics serving a diverse patient population, the reliability and ease of use of lancets make them essential tools for healthcare professionals, contributing to their high demand in clinical settings.
Europe lancet industry is witnessing substantial growth due to the region's aging population, increased prevalence of chronic diseases like diabetes, and a strong emphasis on healthcare quality and patient safety. According to Eurostat, in 2022, the old-age dependency ratio in the EU stood at 33%, showing a 0.5 percentage point rise from the previous year and indicating a consistent upward trend. Over the decade since 2012, this indicator has increased by 5.9 percentage points, starting from 27.1% in that year. These factors drive the demand for lancets, essential for blood glucose monitoring and diagnostics, contributing to the industry's robust expansion in Europe.